top of page

Natco Pharma Ltd

  • Writer: Rajib Kar
    Rajib Kar
  • Mar 2
  • 1 min read

ree

Natco Pharma Ltd. is a 44-year-old pharma company led by Sri V. C. Nannapaneni (Chairman and MD), Sri Rajeev Nannapaneni (Vice Chairman and CEO), and Appa Rao S V V N (CFO), and they have employees of more than 4,800 people globally. They export their products in over 50 countries. Their products are vaccines, pharmaceuticals, pain management solutions, antiviral drugs, generic drugs, cardiovascular products, diabetic products, etc. Natco has shown nearly 30% growth in the last 5 years. However, their revenue is approx. 4,127 crore and their net profit is 1,388 crore for FY 2023-24.

Comments


Subscribe for latest updates • Don’t miss out!

Our Details

© 2035 by Unsold 70

Build a future-ready portfolio with Unsold70

Here is a Gateway of becoming a smart and informed stock market investor. At Unsold70, we bring you powerful stock market basics and a selected list of best 70 companies that are worth investing in. No matter you are a beginner or an experienced investor, our research-driven stock market news helps you uncover undervalued stocks with high growth potential.

 

Our team analyzes the trends, financials, and market movements to provide clear, actionable advice for confident investing. If you have the question how to invest in stock market in your mind, stay ahead with our expert updates, performance tracking, and real-time stock signals.

 

We refine our top 70 list regularly as per the recent stock market changes. Hence, we try to help the investors building a strong, stable, and future-ready portfolio. The right picks today can shape your financial success tomorrow. Explore smarter ways to invest and grow your wealth.

bottom of page